Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.320
-0.060 (-2.52%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Alector Employees
Alector had 103 employees as of December 31, 2025. The number of employees decreased by 135 or -56.72% compared to the previous year.
Employees
103
Change
-135
Growth
-56.72%
Revenue / Employee
$204,320
Profits / Employee
-$1,387,660
Market Cap
256.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | -135 | -56.72% |
| Sep 30, 2025 | 156 | -85 | -35.27% |
| Jun 30, 2025 | 163 | -82 | -33.47% |
| Mar 31, 2025 | 175 | -69 | -28.28% |
| Dec 31, 2024 | 238 | -6 | -2.46% |
| Sep 30, 2024 | 241 | -5 | -2.03% |
| Jun 30, 2024 | 245 | 6 | 2.51% |
| Mar 31, 2024 | 244 | -29 | -10.62% |
| Dec 31, 2023 | 244 | -29 | -10.62% |
| Sep 30, 2023 | 246 | -23 | -8.55% |
| Jun 30, 2023 | 239 | -30 | -11.15% |
| Mar 31, 2023 | 273 | 36 | 15.19% |
| Dec 31, 2022 | 273 | 65 | 31.25% |
| Sep 30, 2022 | 269 | 84 | 45.41% |
| Jun 30, 2022 | 269 | 85 | 46.20% |
| Mar 31, 2022 | 237 | 56 | 30.94% |
| Dec 31, 2021 | 208 | 37 | 21.64% |
| Sep 30, 2021 | 185 | 23 | 14.20% |
| Jun 30, 2021 | 184 | 31 | 20.26% |
| Mar 31, 2021 | 181 | 55 | 43.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| Prelude Therapeutics | 131 |
| Cartesian Therapeutics | 66 |
| Surrozen | 41 |
| Sol-Gel Technologies | 34 |
ALEC News
- 5 days ago - Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 14 days ago - Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Alector to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer - GlobeNewsWire
- 3 months ago - Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Alector to Participate in the Bank of America CNS Therapeutics Conference - GlobeNewsWire
- 3 months ago - ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 4 months ago - Alector Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire